Weikert L F, Edwards K, Chroneos Z C, Hager C, Hoffman L, Shepherd V L
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Am J Physiol. 1997 May;272(5 Pt 1):L989-95. doi: 10.1152/ajplung.1997.272.5.L989.
Surfactant-associated protein A (SP-A) is a C-type lectin that is involved in surfactant metabolism as well as host defense functions in the lung. We have recently identified a receptor on macrophages [specific 210-kDa SP-A receptor (SPR210)] that binds SP-A. In the current study we have investigated the role of SP-A in mediating uptake of bacillus Calmette-Guérin (BCG) by rat macrophages and human monocytes and have examined the role of the macrophage SPR210 in this process. 125I-labeled SP-A bound BCG in a Ca(2+)-, carbohydrate-, and dose-dependent manner. To examine association of SP-A-BCG complexes with macrophages, BCG were opsonized with SP-A and were incubated with rat bone marrow-derived macrophages (RBMM), rat alveolar macrophages (RAM), or human monocytes at a 1-to-1 ratio for 4 h. The cells were washed, fixed in formalin, and stained with auramine-rhodamine. Cell-associated organisms were enumerated by fluorescent microscopy. The percentage of cells with one or more associated BCG was increased by SP-A from 27% of RBMM with BCG alone to 54% with SP-A-BCG complexes; 1-16% in RAM; and 39-67% in human monocytes. This enhanced uptake was dependent on the dose of SP-A, with maximal increases seen with 10 micrograms/ml. Electron microscopic analysis supported the conclusion that organisms were ingested by and not simply bound to the macrophages. Inclusion of SPR210 antibodies blocked association of SP-A-BCG complexes, suggesting a role for SPR210 in mediating the interaction of SP-A-BCG with the macrophages. This was further supported by the finding that modulation of SPR210 activity resulted in altered SP-A-BCG uptake. These results demonstrate that SP-A binds to BCG and that uptake of these SP-A-BCG complexes is mediated in part by the SPR210 on rat macrophages and human monocytes.
表面活性物质相关蛋白A(SP-A)是一种C型凝集素,参与肺表面活性物质代谢以及宿主防御功能。我们最近在巨噬细胞上鉴定出一种与SP-A结合的受体[特异性210 kDa SP-A受体(SPR210)]。在本研究中,我们研究了SP-A在介导大鼠巨噬细胞和人单核细胞摄取卡介苗(BCG)中的作用,并探讨了巨噬细胞SPR210在此过程中的作用。125I标记的SP-A以Ca(2+)、碳水化合物和剂量依赖的方式结合BCG。为了检测SP-A-BCG复合物与巨噬细胞的结合,用SP-A调理BCG,并以1:1的比例与大鼠骨髓来源的巨噬细胞(RBMM)、大鼠肺泡巨噬细胞(RAM)或人单核细胞孵育4小时。细胞经洗涤、用福尔马林固定,并用金胺-罗丹明染色。通过荧光显微镜计数细胞相关的微生物。有一个或多个相关BCG的细胞百分比,单独BCG处理时RBMM为27%,而SP-A-BCG复合物处理时增加到54%;RAM为1%-16%;人单核细胞为39%-67%。这种增强的摄取依赖于SP-A的剂量,10微克/毫升时增加最为显著。电子显微镜分析支持了微生物被巨噬细胞摄取而非简单结合的结论。加入SPR210抗体可阻断SP-A-BCG复合物的结合,表明SPR210在介导SP-A-BCG与巨噬细胞的相互作用中发挥作用。SPR210活性的调节导致SP-A-BCG摄取改变这一发现进一步支持了这一点。这些结果表明,SP-A与BCG结合,这些SP-A-BCG复合物的摄取部分由大鼠巨噬细胞和人单核细胞上的SPR210介导。